However an accompanying Comment cautions the findings are only applicable to patients having periods of maximum virological suppression, and thus have limited application in low income countries.
Dr Amanda Mocroft, Royal Free Centre for HIV Medicine, Royal Free and University College London Medical Schools, and colleagues did a study of 1835 antiretroviral-naive patients from EuroSIDA, a pan-European observational cohort study. These patients, with a mean CD4 cell count of 204 cells per microlitre of blood, then started cART. They were selected because they all responded well to cART and their HIV viral loads were suppressed to below 50 copies per ml for extended periods of time.
The researchers found that the greatest average yearly increase in CD4 count of 100 cells per microlitre was seen in the year immediately following the start of cART. Significant, but lower, yearly increases of around 50 cells per microlitre were seen even five years after beginning cART in some cases, in which patients whose current CD4 count was below 500 cells per microlitre. Patients starting cART with low CD4 cell counts (of less than 200 cells per microlitre) had substantial rises in CD4 counts even after five years. The only groups without substantial increases in CD4 count were those where cART had been taken for more than five years with a current CD4 count of more than 500 cells per microlitre.
The authors conclude: “Normalisation of CD4 counts in HIV-infected patients for all infected individuals might be achievable if viral suppression with cART can be maintained for a sufficiently long period of time.
“We have shown that most patients with HIV who can maintain viral load at less than 50 copies per ml continue to have significant rises in CD4 counts, even after protracted exposure to combination therapy.
“Patients who started cART with a CD4 cell count of more than 350 cells per microlitre had CD4 cells counts approaching the level seen in HIV-negative individuals after more than three years of cART and had no further significant rises in CD4 counts.”
In the accompanying Comment, Dr Gary Maartens and Dr Andrew Boulle, University of Cape Town, South Africa, point out that CD4 cell count when patients start cART is the most important factor is predicting survival – not count increases after cART has begun.
They say: “Mocroft and colleagues’ findings that CD4 counts continue to increase on cART until normal values are reached, even with low CD4 counts at baseline, is only generalisable to patients on cART during periods of maximum virological suppression.”
They conclude: “Nevertheless, the researchers have shown that at least for patients with ideal responses to cART, normalisation of CD4 counts is likely to be achievable across a range of baseline counts.”
Tony Kirby | alfa
Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin
Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care
Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.
Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....
Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.
The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....
An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.
We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...
Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.
Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...
An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...
24.05.2017 | Event News
23.05.2017 | Event News
22.05.2017 | Event News
26.05.2017 | Life Sciences
26.05.2017 | Life Sciences
26.05.2017 | Physics and Astronomy